Michelle Dawson posts

Post published on Twitter/X on 21 Jan 2023 16:04

Twitter/X DOI work crossref Extract quoted in the post External link integrated into the post

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Uarda Petriti, Daniel C. Dudman, Emil Scosyrev, Sandra Lopez-Leon (2023). Global prevalence of Rett syndrome: systematic review and meta-analysis. Systematic Reviews, 12(1), 5. Springer Science and Business Media LLC.

Publication date
16 Jan 2023
Identifier
10.1186/s13643-023-02169-6
Authors
Uarda Petriti, Daniel C. Dudman, Emil Scosyrev, Sandra Lopez-Leon
Source
Systematic Reviews
Details
12(1), 5
Reference type
article
Publisher
Springer Science and Business Media LLC
Metadata source
crossref

Abstract

Abstract Background Rett syndrome is a rare, severe neurodevelopmental disorder. Almost all cases occur in girls, in association with spontaneous (non-inherited) mutations involving the methyl-CpG-binding protein 2 gene located on the X chromosome. Diagnostic criteria for typical Rett syndrome require a period of regression, followed by recovery or stabilization, and fulfillment of all four main criteria (loss of purposeful hand skills, loss of spoken language, gait abnormalities, and stereotypic hand movements). Our objective was to estimate the prevalence of Rett syndrome in the general population, stratified by sex. Methods We conducted a search of PubMed, Embase, Web of Science, Cochrane Library, LILACS, and LIVIVO to retrieve studies published in English between Jan. 1, 2000, and June 30, 2021. Pooled prevalence with a 95% confidence interval (CI) was estimated using a random-effects meta-analysis based on a generalized linear mixed model with a logit link. Results Ten eligible studies were identified (all in females), with a combined sample size of 9.57 million women and 673 Rett syndrome cases. The pooled prevalence estimate (random effects) was 7.1 per 100,000 females (95% CI: 4.8, 10.5, heterogeneity p < 0.001). Despite greatly variable precision of estimation, all estimates were compatible with a prevalence range of approximately 5 to 10 cases per 100,000 females based on their respective 95% CIs. Conclusion These findings may facilitate planning of therapeutic trials in this indication in terms of target sample size and accrual times.

Study authors in this cited reference